Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ELI LILLY & CoLLY · Entity 2794 | EVP & CIDO | February 09, 2026 | February 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ELI LILLY & Co
Report date February 09, 2026 · Filed February 12, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,396.534 |
Reported balance
After 2026-02-09 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-02-09 · Grant · Acquired 4,599.164 · Balance 26,396.534 F1: This amendment to the Form 4 is being filed to report an adjustment of shares withheld from the Reporting Person to cover tax obligations, which amount was previously over-withheld due to an administrative error. |
Filing footnotes · ownership attribution and instrument terms
F1: This amendment to the Form 4 is being filed to report an adjustment of shares withheld from the Reporting Person to cover tax obligations, which amount was previously over-withheld due to an administrative error.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2026 Filed Feb 11, 2026 21:22 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 4,432.32 | $1,044.67 | $4,630,311.73 |
DisclosureSEC source: 0001860253-26-000004 · wk-form4_1770844934.xml · nonDerivative · entry 1 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,229.69 Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 21:22 UTC Amendment | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 4,599.164 | $1,044.67 | $4,804,608.66 |
DisclosureSEC source: 0001860253-26-000006 · wk-form4a_1770931366.xml · nonDerivative · entry 1 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,396.534 F1 · shares: This amendment to the Form 4 is being filed to report an adjustment of shares withheld from the Reporting Person to cover tax obligations, which amount was previously over-withheld due to an administrative error. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:28 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 3,752 | $0.00 | $0.00 |
DisclosureSEC source: 0001860253-26-000002 · wk-form4_1770154111.xml · derivative · entry 3 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,752 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:28 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 1,673.538 | $1,037.15 | $1,735,709.94 |
DisclosureSEC source: 0001860253-26-000002 · wk-form4_1770154111.xml · nonDerivative · entry 2 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,797.37 Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:28 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 3,752 | $0.00 | $0.00 |
DisclosureSEC source: 0001860253-26-000002 · wk-form4_1770154111.xml · nonDerivative · entry 1 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,470.908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:27 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 3,752 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-25-000055 · wk-form4_1739395622.xml · derivative · entry 2 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,752 Underlying: Common Stock · 3,752 shares Expires 2026-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:27 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 6,815.202 | $868.88 | $5,921,592.71 |
DisclosureSEC source: 0000059478-25-000055 · wk-form4_1739395622.xml · nonDerivative · entry 1 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,718.908 Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 21:23 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 3,269 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-25-000024 · wk-form4_1738704227.xml · derivative · entry 3 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,269 shares Expires 2025-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 21:23 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 1,466.294 | $811.08 | $1,189,281.74 |
DisclosureSEC source: 0000059478-25-000024 · wk-form4_1738704227.xml · nonDerivative · entry 2 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,903.706 Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 21:23 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 3,269 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-25-000024 · wk-form4_1738704227.xml · nonDerivative · entry 1 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,370 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:14 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 6,300 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-24-000143 · wk-form4_1717532059.xml · derivative · entry 3 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. F2 · derivative.exercise_date: The restricted stock units vested in three installments, 7,560 on June 1, 2022, 6,300 on June 1, 2023, and 6,300 on June 1, 2024. F2 · derivative.expiration_date: The restricted stock units vested in three installments, 7,560 on June 1, 2022, 6,300 on June 1, 2023, and 6,300 on June 1, 2024. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:14 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 3,045 | $820.34 | $2,497,935.30 |
DisclosureSEC source: 0000059478-24-000143 · wk-form4_1717532059.xml · nonDerivative · entry 2 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,101 Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:14 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 6,300 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-24-000143 · wk-form4_1717532059.xml · nonDerivative · entry 1 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:23 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 3,269 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-24-000040 · wk-form4_1707945812.xml · derivative · entry 2 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,269 Underlying: Common Stock · 3,269 shares Expires 2025-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 20:44 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 6,300 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-23-000186 · wk-form4_1685738624.xml · derivative · entry 3 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,300 Underlying: Common Stock · 6,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. F2 · derivative.exercise_date: The restricted stock units vest in three installments, 7,560 on June 1, 2022, 6,300 on June 1, 2023, and 6,300 on June 1, 2024. F2 · derivative.expiration_date: The restricted stock units vest in three installments, 7,560 on June 1, 2022, 6,300 on June 1, 2023, and 6,300 on June 1, 2024. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 20:44 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 2,848 | $429.46 | $1,223,102.08 |
DisclosureSEC source: 0000059478-23-000186 · wk-form4_1685738624.xml · nonDerivative · entry 2 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,846 Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 20:44 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 6,300 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-23-000186 · wk-form4_1685738624.xml · nonDerivative · entry 1 Rau Diogo · CIK 0001860253 · EVP & CIDO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,694 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 22:41 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 7,560 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-22-000161 · wf-form4_165420964136601.xml · derivative · entry 3 Rau Diogo · CIK 0001860253 · SVP & CIDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,600 Underlying: Common Stock · 7,560 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. F2 · derivative.exercise_date: The restricted stock units vest in three installments, 7,560 on June 1, 2022, 6,300 on June 1, 2023, and 6,300 on June 1, 2024. F2 · derivative.expiration_date: The restricted stock units vest in three installments, 7,560 on June 1, 2022, 6,300 on June 1, 2023, and 6,300 on June 1, 2024. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 22:41 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 3,166 | $313.44 | $992,351.04 |
DisclosureSEC source: 0000059478-22-000161 · wf-form4_165420964136601.xml · nonDerivative · entry 2 Rau Diogo · CIK 0001860253 · SVP & CIDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,394 Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 22:41 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 7,560 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-22-000161 · wf-form4_165420964136601.xml · nonDerivative · entry 1 Rau Diogo · CIK 0001860253 · SVP & CIDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:41 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 20,160 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000141 · wf-form4_162275644126655.xml · derivative · entry 1 Rau Diogo · CIK 0001860253 · SVP & CIDO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,160 Underlying: Common Stock · 20,160 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. F2 · derivative.exercise_date: The restricted stock units vest in three installments, 7,560 on June 1, 2022, 6,300 on June 1, 2023, and 6,300 on June 1, 2024. F2 · derivative.expiration_date: The restricted stock units vest in three installments, 7,560 on June 1, 2022, 6,300 on June 1, 2023, and 6,300 on June 1, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.